Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02128802 · ClinicalTrials.gov registry record · NA
Obesity Surgery and Kidney Transplant for Patients With Obesity and Renal Failure
A NA study of Renal Failure and Severe Obesity, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT02128802: Completed NA study of Renal Failure and Severe Obesity, sponsored by Vanderbilt University Medical Center.
NCT02128802 is a NA study of Renal Failure and Severe Obesity that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 20 participants, below the 300-participant average among 11 other Renal Failure trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02128802, a NA study of Renal Failure and Severe Obesity, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Gastric Bypass followed by renal transplantation is superior to medical management followed by renal transplant for patients with severe obesity and renal failure.
Primary Outcome
Outcomes will be measured based on weight loss and a variety of validated surveys and questionnaires to measure HRQOL
Conditions Studied
Interventions
- PROCEDURE Gastric Bypass
- OTHER Weight Loss Program
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-04-01 |
| Est. Completion | 2024-03-28 |
| Phase | NA |
What the finished NCT02128802 record still lists
NCT02128802 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 300-participant average among 11 other Renal Failure trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Renal Failure appearing as the primary indexed condition, and to 2 interventions - of which Gastric Bypass is the first listed.
NCT02128802 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT02128802 about?
NCT02128802 is a clinical study titled "Obesity Surgery and Kidney Transplant for Patients With Obesity and Renal Failure". Gastric Bypass followed by renal transplantation is superior to medical management followed by renal transplant for patients with severe obesity and renal failure.
What is the current status of trial NCT02128802?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2014-04-01. Estimated completion is 2024-03-28.
What conditions does trial NCT02128802 study?
This clinical trial studies the following conditions: Renal Failure, Severe Obesity.
What interventions are being tested in trial NCT02128802?
The interventions under investigation include: Gastric Bypass (PROCEDURE), Weight Loss Program (OTHER).
Who is sponsoring clinical trial NCT02128802?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02128802 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02128802's enrollment target sits among peer trials
20 8th of 11 higher than 2 of 11 other Renal Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Renal Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post-Filter Hematocrit
RECRUITING · NA
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Improving Patient Prioritization During Hospital-homecare Transition
COMPLETED · NA
-
Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure
RECRUITING · Early Phase 1
-
Prevent Cardiac Surgery Associated AKI Trial
RECRUITING · Phase 2
-
Renal Allograft Tolerance Through Mixed Chimerism - SMC/MGH
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI